Skip to main content
PMC home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1987 Nov;56(5):629–632. doi: 10.1038/bjc.1987.256

Early detection of liver metastasis in patients with colorectal carcinoma by increased levels of circulating IgA- and IgM-associated secretory component.

D Kvale 1, T O Rognum 1, P Brandtzaeg 1
PMCID: PMC2001875  PMID: 3426927

Abstract

One hundred patients operated for colorectal carcinoma were followed clinically and with serial blood samples from 5 to 8 years. Levels of secretory component (SC) associated with IgA and IgM in serum were measured and related to Dukes' stage, histological differentiation, tumour expression of SC, and circulating carcinoembryonic antigen (CEA). On the whole, elevated levels of SC in serum were found in 15 of the 20 patients who already had (n = 15), or later developed (n = 5), liver metastasis. Four of the latter 5 patients showed raised SC levels with a 5.5 months median lead time from the first positive serum sample to clinically manifest liver disease. These data are interesting in view of the promising results reported for liver resection in patients with colorectal carcinoma.

Full text

PDF
629

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Adson M. A., Van Heerden J. A. Major hepatic resections for metastatic colorectal cancer. Ann Surg. 1980 May;191(5):576–583. doi: 10.1097/00000658-198005000-00009. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Arends J. W., Wiggers T., Thijs C. T., Verstijnen C., Swaen G. J., Bosman F. T. The value of secretory component (SC) immunoreactivity in diagnosis and prognosis of colorectal carcinomas. Am J Clin Pathol. 1984 Sep;82(3):267–274. doi: 10.1093/ajcp/82.3.267. [DOI] [PubMed] [Google Scholar]
  3. Brandtzaeg P. Human secretory immunoglobulins. V. Occurrence of secretory piece in human serum. J Immunol. 1971 Feb;106(2):318–323. [PubMed] [Google Scholar]
  4. Brandtzaeg P. Role of J chain and secretory component in receptor-mediated glandular and hepatic transport of immunoglobulins in man. Scand J Immunol. 1985 Aug;22(2):111–146. doi: 10.1111/j.1365-3083.1985.tb01866.x. [DOI] [PubMed] [Google Scholar]
  5. Brooks J. J., Ernst C. S. Immunoreactive secretory component of IgA in human tissues and tumors. Am J Clin Pathol. 1984 Dec;82(6):660–665. doi: 10.1093/ajcp/82.6.660. [DOI] [PubMed] [Google Scholar]
  6. Delacroix D. L., Courtoy P. J., Rahier J., Reynaert M., Vaerman J. P., Dive C. Localization and serum concentration of secretory component during massive necrosis of human liver. Gastroenterology. 1984 Mar;86(3):521–531. [PubMed] [Google Scholar]
  7. Delacroix D. L., Elkom K. B., Geubel A. P., Hodgson H. F., Dive C., Vaerman J. P. Changes in size, subclass, and metabolic properties of serum immunoglobulin A in liver diseases and in other diseases with high serum immunoglobulin A. J Clin Invest. 1983 Feb;71(2):358–367. doi: 10.1172/JCI110777. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Gotoh T., Takishita Y., Doi H., Tsubura E. Secretory-component-producing lung cancer with hypergammaglobulinemia of secretory IgA. Cancer. 1981 Oct 15;48(8):1776–1782. doi: 10.1002/1097-0142(19811015)48:8<1776::aid-cncr2820480814>3.0.co;2-r. [DOI] [PubMed] [Google Scholar]
  9. Harris J. P., South M. A. Secretory component: a glandular epithelial cell marker. Am J Pathol. 1981 Oct;105(1):47–53. [PMC free article] [PubMed] [Google Scholar]
  10. Homburger H. A., Casey M., Jacob G. L., Klee G. G. Measurement of secretory IgA in serum by radioimmunoassay in patients with chronic nonalcoholic liver disease or carcinoma. Am J Clin Pathol. 1984 May;81(5):569–574. doi: 10.1093/ajcp/81.5.569. [DOI] [PubMed] [Google Scholar]
  11. Iwatsuki S., Shaw B. W., Jr, Starzl T. E. Experience with 150 liver resections. Ann Surg. 1983 Mar;197(3):247–253. doi: 10.1097/00000658-198303000-00001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Kvale D., Brandtzaeg P. An enzyme-linked immunosorbent assay for differential quantitation of secretory immunoglobulins of the A and M isotypes in human serum. J Immunol Methods. 1986 Jan 22;86(1):107–114. doi: 10.1016/0022-1759(86)90272-3. [DOI] [PubMed] [Google Scholar]
  13. Kvale D., Rognum T. O., Brandtzaeg P. Elevated levels of secretory immunoglobulins A and M in serum of patients with large bowel carcinoma indicate liver metastasis. Cancer. 1987 Jan 15;59(2):203–207. doi: 10.1002/1097-0142(19870115)59:2<203::aid-cncr2820590204>3.0.co;2-p. [DOI] [PubMed] [Google Scholar]
  14. Kvale D., Schrumpf E., Brandtzaeg P., Solberg H. E., Fausa O., Elgjo K. Circulating secretory immunoglobulins of the A and M isotypes in chronic liver disease. J Hepatol. 1987 Apr;4(2):229–235. doi: 10.1016/s0168-8278(87)80085-5. [DOI] [PubMed] [Google Scholar]
  15. Ohman U. Colorectal carcinoma. A survey of 1345 cases 1950-1984. Acta Chir Scand. 1985;151(8):675–679. [PubMed] [Google Scholar]
  16. Orjasaeter H., Fosså S. D., Schjølseth S. A., Fjaestad K. Carcinoembryonic antigen (CEA) in plasma of patients with carcinoma of the bladder/urethra. Cancer. 1978 Jul;42(1):287–295. doi: 10.1002/1097-0142(197807)42:1<287::aid-cncr2820420143>3.0.co;2-l. [DOI] [PubMed] [Google Scholar]
  17. Poger M. E., Hirsch B. R., Lamm M. E. Synthesis of secretory component by colonic neoplasms. Am J Pathol. 1976 Feb;82(2):327–338. [PMC free article] [PubMed] [Google Scholar]
  18. Rognum T. O., Heier H. E., Orjasaeter H., Thorud E., Brandtzaeg P. Comparison of two CEA assays in primary and recurrent large bowel carcinoma with different DNA ploidy pattern. Eur J Cancer Clin Oncol. 1986 Oct;22(10):1165–1169. doi: 10.1016/0277-5379(86)90317-2. [DOI] [PubMed] [Google Scholar]
  19. Rognum T. O., Thorud E., Brandtzaeg P. Preservation of cytometric DNA distribution and epithelial marker expression after tumor progression of human large bowel carcinomas. Cancer. 1985 Oct 1;56(7):1658–1666. doi: 10.1002/1097-0142(19851001)56:7<1658::aid-cncr2820560732>3.0.co;2-2. [DOI] [PubMed] [Google Scholar]
  20. Rognum T., Elgjo K., Brandtzaeg P., Orjasaeter H., Bergan A. Plasma carcinoembryonic antigen concentrations and immunohistochemical patterns of epithelial marker antigens in patients with large bowel carcinoma. J Clin Pathol. 1982 Sep;35(9):922–933. doi: 10.1136/jcp.35.9.922. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Solberg H. E. The theory of reference values Part 5. Statistical treatment of collected reference values. Determination of reference limits. J Clin Chem Clin Biochem. 1983 Nov;21(11):749–760. [PubMed] [Google Scholar]
  22. Stern J. E., Underdown B. J., Crichlow R. W., Wira C. R. Secretory component in breast cancer. Analysis of the levels in primary and metastatic disease. Cancer Immunol Immunother. 1985;19(3):226–230. doi: 10.1007/BF00199231. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Tomana M., Phillips J. O., Kulhavy R., Mestecky J. Carbohydrate-mediated clearance of secretory IgA from the circulation. Mol Immunol. 1985 Aug;22(8):887–892. doi: 10.1016/0161-5890(85)90074-4. [DOI] [PubMed] [Google Scholar]
  24. Turnbull R. B., Jr, Kyle K., Watson F. R., Spratt J. Cancer of the colon: the influence of the no-touch isolation technic on survival rates. Ann Surg. 1967 Sep;166(3):420–427. doi: 10.1097/00000658-196709000-00010. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Vecchio T. J. Predictive value of a single diagnostic test in unselected populations. N Engl J Med. 1966 May 26;274(21):1171–1173. doi: 10.1056/NEJM196605262742104. [DOI] [PubMed] [Google Scholar]
  26. Wilson S. M., Adson M. A. Surgical treatment of hepatic metastases from colorectal cancers. Arch Surg. 1976 Apr;111(4):330–334. doi: 10.1001/archsurg.1976.01360220026004. [DOI] [PubMed] [Google Scholar]
  27. Wood C. B., Gillis C. R., Blumgart L. H. A retrospective study of the natural history of patients with liver metastases from colorectal cancer. Clin Oncol. 1976 Sep;2(3):285–288. [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES